Here we report that the human DNA mismatch complex MSH2-MSH3 recognizes small loops by a mechanism different from that of MSH2-MSH6 for single-base mismatches. The subunits MSH2 and MSH3 can bind either ADP or ATP with similar affinities. Upon binding to a DNA loop, however, MSH2-MSH3 adopts a single 'nucleotide signature', in which the MSH2 subunit is occupied by an ADP molecule and the MSH3 subunit is empty. Subsequent ATP binding and hydrolysis in the MSH3 subunit promote ADP-ATP exchange in the MSH2 subunit to yield a hydrolysis-independent ATP-MSH2-MSH3-ADP intermediate. Human MSH2-MSH3 and yeast Msh2-Msh6 both undergo ADP-ATP exchange in the Msh2 subunit but, apparently, have opposite requirements for ATP hydrolysis: ADP release from DNA-bound Msh2-Msh6 requires ATP stabilization in the Msh6 subunit, whereas ADP release from DNA-bound MSH2-MSH3 requires ATP hydrolysis in the MSH3 subunit. We propose a model in which lesion binding converts MSH2-MSH3 into a distinct nucleotide-bound form that is poised to be a molecular sensor for lesion specificity.
The mismatch repair (MMR) system binds and corrects mispaired or extrahelical base lesions within DNA. MMR supports the intrinsic proofreading properties of DNA polymerases during replication and decreases the mutation rate of newly replicated DNA by nearly 1,000-fold [1] [2] [3] . MMR proteins also correct heteroduplex DNA after recombination events, and they have been linked functionally to base and nucleotide-excision repair pathways 4, 5 . In mammals, loss of MMR function confers a mutator phenotype and contributes to the development of cancers, such as hereditary nonpolyposis colorectal cancer (HNPCC) and sporadic solid tumors [6] [7] [8] .
Many steps of MMR are not well understood, but the structural and functional basis for lesion recognition has been derived from studies on prokaryotic MutS 9,10 and eukaryotic Msh2-Msh6 (ref. 11). For both the MutS homodimer and the Msh2-Msh6 heterodimer, DNA binding is asymmetric, with one subunit in direct contact with a mispaired base and the other making nonspecific contacts with the phosphodiester backbone 9, 10 . Both MMR complexes contain a conserved Phe-X-Glu motif in which the phenylalanine residue stacks onto the mispaired DNA base [9] [10] [11] [12] and is essential for efficient repair [1] [2] [3] 13 . MutS and Msh2-Msh6 each bind and hydrolyze ATP [13] [14] [15] [16] [17] [18] within two conserved Walker-type nucleotide binding domains, both of which form as a composite site comprising the C terminus of each subunit [9] [10] [11] [12] .
In eukaryotes, a second MMR complex, Msh2-Msh3 (refs. 1-3), can carry out lesion recognition. Although they share a common Msh2 subunit, Msh3 and Msh6 have little sequence homology in their DNA binding domains, and the complexes have different lesion specificities [1] [2] [3] . Msh2-Msh6 has a high affinity for single-base mismatches or an unpaired base, as measured by both DNA binding and ATPase activity [19] [20] [21] . Recent data have suggested that Msh2-Msh3 can repair some base-base mispairs 22 , but it seems to have higher affinity and specificity for insertion/deletion DNA loops (IDL) composed of 2-13 bases [1] [2] [3] 18, 23, 24 .
The underlying basis for lesion specificity between the two MMR complexes is poorly understood but is likely to reside in Msh3-and Msh6-specific sequences. Changes in any of the Phe-X-Glu residues of Msh6 result in a strong mutator phenotype, suggesting that these residues are essential for effective repair of single-base mismatches 13 . However, at the analogous position of Phe-X-Glu in Msh6, both yeast and human Msh3 (Msh3 and MSH3, respectively) have a lysine instead of phenylalanine, and lysine or arginine instead of glutamate [1] [2] [3] [9] [10] [11] [12] . Thus, repair by Msh2-Msh3 and Msh2-Msh6, even for the same lesion, is unlikely to occur by the same mechanism [1] [2] [3] 12, 24 . For yeast Msh2-Msh6, replacement of the DNA binding domain of Msh6 with the equivalent domain of Msh3 results in a chimera that is functional for mismatch repair and possesses the DNA binding specificity of Msh3 (ref. 25) . The effect is not reversible: a chimeric MSH2-MSH3 protein harboring the DNA binding domain of yeast Msh6 does not complement an yeast Msh6-deletion mutant 25 . Furthermore, yeast strains bearing a deletion in domain 1 of Msh2 are phenotypically nearly wild type in Msh2-Msh6-mediated MMR and recombination, but they are defective in Msh2-Msh3-mediated MMR and recombination functions 26 . These data suggest that the Msh3 and Msh6 subunits are structurally and functionally different. © 2009 Nature America, Inc. All rights reserved.
Despite extensive differences in their properties, initiation of repair by both Msh2-Msh3 and Msh2-Msh6 require coupling of DNA binding and ATP hydrolysis [13] [14] [15] [16] [17] [18] . Recent mapping studies of yeast Msh2-Msh6 indicate that the Msh6 subunit binds ATP with high apparent affinity, whereas Msh2 binds exclusively ADP 18 . Notably, lesion binding does not alter either the nucleotide binding properties 18 or the conformation 11 of Msh2-Msh6. A model has been proposed in which both the Msh2 and Msh6 subunits of Msh2-Msh6 are simultaneously occupied with ATP to form a 'hydrolysis-independent' intermediate capable of end-dependent dissociation [15] [16] [17] [18] . Differential nucleotide occupancy, therefore, is a major determinant for Msh2-Msh6 to initiate repair of single-base mismatches [1] [2] [3] 18, [27] [28] [29] .
The biochemical properties of Msh2-Msh3 have been largely inferred from those of bacterial MutS or its eukaryotic homolog, Msh2-Msh6, although they recognize distinct lesions and differ in their DNA binding domains. Despite the fact that small heteroduplex loops are among the most frequent lesions in DNA, the mechanism by which Msh2-Msh3 might recognize and repair the loops is not understood, and the nucleotide binding properties have not been measured. To begin addressing this issue, we have purified the human MSH2-MSH3 (ref. 30 ) and MSH2-MSH6 complexes, measured the nucleotide binding affinities in each complex and mapped the nucleotide subunit occupancy during lesion recognition. On the basis of our findings, we propose a new model for the recognition and repair of small loops by MSH2-MSH3 that differs substantially from the mechanism of recognition and repair of single-base mismatches by Msh2-Msh6.
RESULTS

Nucleotide binding is similar in yeast and human Msh2-Msh6
The apparent affinity and subunit specificity for ADP and ATP has been recently reported for yeast Msh2-Msh6 18 . Therefore, as a reference point for evaluating MSH2-MSH3, we first determined whether there were substantial differences between the nucleotide binding profiles of the yeast and human Msh2-Msh6 complexes. To map the subunit occupancy and nucleotide affinity, we performed UV cross-linking of [a-32 P]ADP or [a-32 P]ATP to MSH2-MSH6 and resolved the cross-linking products by PAGE (Fig. 1) . Because covalent attachment depends on the geometry of the binding sites and is irreversible, cross-linking can overestimate affinity if there is nonspecific binding or underestimate affinity if cross-linking is inefficient. To avoid potential artifacts, we also measured equilibrium binding of fluorescent Bo-Dipy (BD)-labeled nucleotides in solution using fluorescence anisotropy. The calculated K d values are indicated in the figures, and a summary of the measured affinities with statistics is listed (Supplementary Table 1 online) . In all experiments, we confirmed that contamination within an ADP, ATP or AMP-PNP preparation was less than 1% ( Supplementary Fig. 1a online) or, in the case of ATP, an ATP-regeneration system was included in the reaction ( Supplementary Fig. 1b) . We checked purified MMR complexes with a sensitive luciferase assay 28 to ensure that any prebound ADP nucleotide had been removed.
The nucleotide binding properties of MSH2-MSH6 were similar to those of Msh2-Msh6 (Fig. 1a,b and Supplementary Table 1a) . For ADP, the high-affinity binding site resided in MSH2, whereas MSH6 did not show quantifiable cross-linking at concentrations up to 100 mM ( Fig. 1a and Supplementary Fig. 2a online) . We obtained similar results from experiments using equilibrium binding of BD-ADP(+Mg 2+ ) (Supplementary Table 1b) .
We observed similar ATP binding properties with MSH2-MSH6 and Msh2-Msh6 (Fig. 1b) . ATP can be hydrolyzed during the course of binding reactions; therefore, we measured the ATP binding reaction under nonhydrolyzing conditions, using either [a-32 P]ATP(-Mg 2+ ) or a nonhydrolyzable ATP analog, AMP-PNP(+Mg 2+ ). As reported for yeast Msh2-Msh6, ATP bound with high affinity to the MSH6 subunit of human MSH2-MSH6 (Fig. 1b, Supplementary Table 1a and Supplementary Fig. 2a ). The level of cross-linking of [a-32 P]ATP (-Mg 2+ ) to the MSH2 subunit was only a fraction (about 20%) of that covalently attached to MSH6 (Fig. 1b and Supplementary Table 1a) , suggesting a low ATP affinity of MSH2. However, binding was saturable (Fig. 1b) , and, in solution, the K d for BD-ATP(-Mg 2+ ) and BD-AMP-PNP(+Mg 2+ ) to the MSH2 subunit was 390 nM and 230 nM, respectively (Supplementary Table 1b ). The BD tag did not affect the measured affinity of BD-ATP(-Mg 2+ ), because the K d for binding of BD-ATP(-Mg 2+ ) and the K i for its inhibition by an unlabeled ATP(-Mg 2+ ) were equivalent (Supplementary Table 1a,c). Thus, cross-linking, but not binding, of [a-32 P]ATP(-Mg 2+ ) to the MSH2 subunit of MSH2-MSH6 was inefficient. As a whole, however, the nucleotide binding properties of ADP and ATP to MSH2-MSH6 and to Msh2-Msh6 were comparable. In both species, the MSH2 subunit was a high-affinity binding site for ADP and the MSH6 subunit was a high-affinity binding site for ATP.
The subunits of MSH2-MSH3 bind ADP and ATP stochastically The nucleotide binding properties of MSH2-MSH3 were distinct from those of MSH2-MSH6 (Fig. 2) . As quantified by the gel scans ( Supplementary Fig. 2b To further test the stochastic binding of nucleotides, we simultaneously added a constant amount (5 mM) of labeled ADP(+Mg 2+ ) and increasing concentrations of unlabeled AMP-PNP(+Mg 2+ ) to MSH2-MSH3 (Fig. 2c, left) . If nucleotide binding was stochastic, then ADP and ATP, when added together, should compete equally well for binding to each subunit of MSH2-MSH3. Indeed, as the concentration of the unlabeled AMP-PNP(+Mg 2+ ) approached the concentration of the labeled ADP(+Mg 2+ ), cross-linking to each subunit was reduced to the same extent (Fig. 2c, left) . In a complementary experiment, we simultaneously added a constant concentration of unlabeled AMP-PNP(+Mg 2+ ) (5 mM) with increasing concentrations of labeled [a-32 P]ADP(+Mg 2+ ) (Fig. 2c, right) . As the concentration of the labeled [a-32 P]ADP(+Mg 2+ ) approached that of unlabeled AMP-PNP(+Mg 2+ ), cross-linking to each subunit increased to the same extent. Thus, the nucleotide binding properties of MSH2-MSH3 were significantly different from those of MSH2-MSH6. ADP and ATP did not discriminate between the subunits of MSH2-MSH3.
Neither ATP nor ADP binds both subunits simultaneously In all MutS heterodimers, the two composite Walker-type ATP binding sites are found in close proximity to each other at the subunit interface [9] [10] [11] . Because ADP and ATP showed no preference for the subunits of MSH2-MSH3, we tested whether the same nucleotide could occupy both sites simultaneously. To measure the stoichiometry of MSH2-MSH3 to ADP(+Mg 2+ ), we used a filter binding assay with [ 3 H]ADP(+Mg 2+ ). If both nucleotide binding sites were occupied, the ratio of labeled [ 3 H]ADP(+Mg 2+ ) to the heterodimeric MSH2-MSH3 should be 2, whereas an equimolar ratio would indicate that only one site was occupied. Indeed, we observed that [ 3 H]-ADP(+Mg 2+ ) binding was equimolar and occupied one of the available nucleotide binding sites (Fig. 3a) . We obtained similar results for ATP by fluorescence anisotropy, with saturation at 0.9 moles of ATP bound per mole of MSH2-MSH3 heterodimer (Fig. 3b) . Thus, ADP or ATP binding in one Walker site excluded binding in the other, leading to four distinct nucleotide-bound complexes of MSH2-MSH3 in the absence of hydrolysis (Fig. 3c) . © 2009 Nature America, Inc. All rights reserved. To evaluate which of the four forms might be available for DNA binding, we tested whether the proportion of ATP-and ADP-bound species of MSH2-MSH3 changed under hydrolytic conditions. We incubated MSH2-MSH3 with [a-32 P]ATP or [g-32 P]ATP in the presence or absence of magnesium and evaluated the products after cross-linking (Fig. 3d) . The retention or loss of the labeled phosphate was used to determine whether ATP bound to the respective subunits and whether the bound ATP was hydrolyzed (see Fig. 3d for a schematic of the possible outcomes). [a-32 P]ATP cross-linked to a similar extent in both subunits of MSH2-MSH3 under nonhydrolyzing and hydrolyzing conditions (Fig. 3d, i,iv) , and the cross-linking of [gÀ 32 P]ATP was similar to that of [a-32 P]ATP under nonhydrolyzing conditions (Fig. 3d, i,ii) . In the presence of magnesium, however, the [g 32 P]ATP(+Mg 2+ ) signal was lost in both subunits (Fig. 3d, iii) . Thus, both subunits of MSH2-MSH3 bound and hydrolyzed ATP, and both retained the ADP product.
ADP-bound forms of MSH2-MSH3 are stable in solution Stochastic binding predicted that the ADP hydrolysis products bound in the MSH2-MSH3 subunits would freely exchange with ADP or ATP in solution. Given the excess of ATP in the cells 31 , therefore, a population of ATP-bound MSH2-MSH3 should be maintained. However, ADP occupation of the MSH2 changed the nucleotide binding dynamics. In these experiments, we tested the ability of added AMP-PNP(+Mg 2+ ) or ADP(+Mg 2+ ) to displace prebound BD-ADP(+Mg 2+ ) within the subunits of MSH2-MSH3 (Fig. 4) . As ADP binds equally well to either subunit, BD-ADP-MSH2-MSH3-empty and empty-MSH2-MSH3-BD-ADP (where 'empty' indicates the absence of nucleotide bound) should be present in equal amounts at the beginning of the experiment. However, competition with either AMP-PNP(+Mg 2+ ) or ADP(+Mg 2+ ) failed to displace half of the prebound BD-ADP (Fig. 4a) . One of the MSH2-MSH3 subunits did not release its bound ADP.
To determine which complex retained ADP, we repeated the experiment using prebound [a-32 P]ADP(+Mg 2+ ), and cross-linked it during the competition. Even at a 100-fold molar excess of AMP-PNP(+Mg 2+ ) or ADP(+Mg 2+ ), MSH2 did not completely release its bound [a-32 P]ADP(+Mg 2+ ) during the cross-linking period (Fig. 4c,d) , not even after 4 h ( Supplementary Fig. 3 online) .
ADP binding to the MSH3 subunit of MSH2-MSH3 was more dynamic, but its exchange was selective (Fig. 4c,d) . Dissociation of the prebound ADP by added ADP was reversible (compare K d and K i for ADP in Supplementary Table 1a,c) , and occurred by simple competition (Fig. 4b, above) . However, dissociation of prebound ADP by added ATP occurred by a different pathway: BD-ADP(+Mg 2+ ) and BD-AMP-PNP(+Mg 2+ ) bound to MSH3 with a similar affinity (Supplementary Table 1b) , but the K i for AMP-PNP(+Mg 2+ )-induced dissociation of BD-ADP(+Mg 2+ ) was 40-fold higher (Fig. 4c,d ). These results were consistent with a model in which AMP-PNP binds first to the empty MSH2 and displaces ADP from MSH3 (Fig. 4b, below) . Thus, ADP-bound forms of MSH2-MSH3 were stable in solution, even when ATP was in excess. ADP bound to the MSH2 subunit did not exchange with other nucleotides in solution. ATP binding in the MSH2 subunit could displace ADP in the MSH3 subunit, but MSH3-bound ATP was hydrolyzed to ADP.
The nucleotide-bound state of MSH2-MSH3 is lesion dependent The main function for MutS-related complexes is lesion recognition. Because ADP-MSH2-MSH3-empty and empty-MSH2-MSH3-ADP were prominent in solution, we tested whether one or both bound to DNA, and whether DNA binding altered the nucleotide affinity (Fig. 5) . We added apo-MSH2-MSH3 (without nucleotide) to different DNA molecules (perfectly matched or mismatched) to form stoichiometric DNA-protein complexes, and we assessed nucleotide affinity by measuring the cross-linking of [a-32 P]ADP(+Mg 2+ ), [a-32 P]ATP (-Mg 2+ ), or [a-32 P]AMP-PNP(+Mg 2+ ) (Fig. 5) . DNA had no appreciable effect on the binding of nucleotides to MSH2 in MSH2-MSH6 (Fig. 5a and Supplementary Table 1a and Supplementary Fig. 4) . However, DNA binding reduced the affinity of ADP to MSH3 five-fold when bound to homoduplex DNA and ten-fold when bound to a small heteroduplex loop comprising four CA residues ((CA) 4 -loop DNA) ( Fig. 5a and Supplementary Fig. 5 online) . Thus, DNA binding strongly inhibited ADP occupation of the MSH3 subunit, suggesting that empty-MSH2-MSH3-ADP might not bind stably to the lesion.
To test this possibility, we added fluorescein (FL)-labeled DNA to stoichiometric amounts of ADP(+Mg 2+ )-bound MSH2-MSH3 (Fig. 5b, left) and used fluorescence anisotropy to measure the K d for binding to the (CA) 4 -loop DNA (Fig. 5b, right) . The change in anisotropy for ADP-MSH2-MSH3 binding to DNA is half of that measured for MSH2-MSH3 binding without added ADP, suggesting that only one of the two ADP-bound MSH2-MSH3 complexes shown at left in Figure 5b can bind DNA. As ADP primarily occupied the MSH2 subunit of MSH2-MSH3 when bound to DNA (Fig. 5a) , ADP-MSH2-MSH3-empty, but not empty-MSH2-MSH3-ADP, was competent for DNA binding. ATP had little affinity for DNA-bound MSH2-MSH3 ( Fig. 5c and Supplementary Fig. 6a,b online) . For the MSH2 subunit, ATP (-Mg 2+ ) binding affinity decreased five-fold when bound to homoduplex DNA and ten-fold when bound to the (CA) 4 -loop, compared to no DNA ( Fig. 5c and Supplementary Table 1a) . The impact of DNA binding on MSH3 was even higher. The apparent affinity of ATP to MSH3 decreased by 100-fold with homoduplex and nearly 200-fold when bound to the (CA) 4 -loop DNA, essentially rendering MSH3 an 'empty' nucleotide binding site ( Fig. 5c and Supplementary Table  1a ). This was supported by cross-linking results with AMP-PNP ( Supplementary Fig. 6c) . Thus, only ADP-MSH2-MSH3-empty bound stably to the lesion.
ATP hydrolysis in MSH3 enhances ADP-ATP exchange in MSH2
In repair of single-base mismatches, nucleotides occupy both subunits of MutSa or Msh2-Msh6 when they are bound to heteroduplex DNA, and ATP hydrolysis initiates downstream repair [1] [2] [3] . As MSH2 in MSH2-MSH3 binds ADP tightly, we tested whether DNA-bound MSH2-MSH3 could be doubly occupied with two different nucleotides and whether the nucleotide binding dynamics were influenced by ATP hydrolysis (Fig. 6) . To address these issues, ADP was prebound to MSH2-MSH3 in the presence or absence of DNA, and we monitored nucleotide occupancy by cross-linking under hydrolyzing (ATP(+Mg 2+ )) and nonhydrolyzing (AMP-PNP(+Mg 2+ )) conditions. We followed ADP dissociation from the MSH2 subunit by measuring loss of the [a-32 P]ADP(+Mg 2+ ) cross-linking signal, whereas ATP binding and hydrolysis was indicated by the gain of the [a-32 P]ATP(+Mg 2+ ) and the loss of the [g-32 P]ATP(+Mg 2+ ) cross-linking signals, respectively, using the appropriate labeled nucleotide (Fig. 6) .
In the absence of DNA, addition of ATP(+Mg 2+ ) displaced a modest amount of ADP from the MSH2 subunit (Fig. 6a, left) . Dissociation of ADP was mirrored by a comparable gain in ATP binding (Fig. 6c, above left) , which was subsequently hydrolyzed (Fig. 6d, left) . Thus, under hydrolytic conditions, ATP binding in the MSH3 subunit allowed MSH2 to release some of its bound ADP, which was not exchangeable under nonhydrolyzing conditions (Figs. 4c,d and 6b) .
In the presence of DNA, however, hydrolytic conditions not only promoted double occupancy of (CA) 4 -loop-bound ADP-MSH2-MSH3-empty, but also resulted in three key effects relative to the DNA-free complex (Fig. 6) . First, release of ADP in the MSH2 subunit of (CA) 4 -loop-bound ADP-MSH2-MSH3-empty required ATP binding and hydrolysis in the MSH3 subunit (compare Fig. 6a,b, middle) . The loss of the [a-32 P]ADP(+Mg 2+ ) cross-linking signal occurred only when ATP(+Mg 2+ ) was the competitor. Second, binding of [a-32 P]ATP(+Mg 2+ ) in the MSH3 subunit of (CA) 4 -loop-bound ADP-MSH2-MSH3-empty increased the affinity of ATP for the MSH2 subunit, resulting in ADP-ATP exchange (Fig. 6c, middle) . Third, after exchange, ATP hydrolysis in the MSH2 subunit was inhibited (Fig. 6d, compare left and right) . Thus, under hydrolytic conditions, binding of ATP(+Mg 2+ ) in the MSH3 subunit of (CA) 4 loop-bound MSH2-MSH3 led to conversion of (CA) 4 -loop-bound ADP-MSH2-MSH3-empty into a hydrolysis-independent ATP-MSH2-MSH3-ADP intermediate.
Binding to the (CA) 4 loop suppresses ADP-ATP exchange
To test whether the nucleotide dynamics of MSH2-MSH3 depended on binding to the heteroduplex loop, we prebound MSH2-MSH3 to excess homoduplex DNA and repeated the cross-linking experiments. Under these conditions, ATP was an even better competitor for prebound [a-32 P]ADP(+Mg 2+ ) compared to (CA) 4 -loop-bound [a-32 P]ADP(+Mg 2+ ) ADP(+Mg 2+ ) or to MSH2-MSH3 in the absence of DNA (Fig. 6a) . Thus, interaction of ADP-MSH2-MSH3 with the (CA) 4 heteroduplex loop suppressed ADP-ATP exchange in the MSH2 subunit relative to perfectly paired DNA.
Suppression of ATP hydrolysis promotes DNA dissociation
We further investigated the double occupancy of (CA) 4 -loop-bound ADP-MSH2-MSH3 when ATP hydrolysis was prevented. In these kinetics experiments, as before, we added the fluorescent analog BD-ADP in a 1:1 ratio to preformed stoichiometric complexes of (CA) 4 -loop DNA and MSH2-MSH3. Thus, the MSH2-MSH3 heterodimers were bound to DNA, and only the MSH2 subunit was bound with BD-ADP (Fig. 6e) . We added unlabeled ADP(+Mg 2+ ) or AMP-PNP(+Mg 2+ ) as a competitor (500 mM) and followed BD-ADP dissociation by fluorescence anisotropy for 1 h (Fig. 6e) . Unlabeled ADP(+Mg 2+ ) competed directly for and displaced a substantial amount of the prebound BD-ADP(+Mg 2+ ) in the (CA) 4 loop-bound ADP-MSH2-MSH3-empty. In contrast, addition of nonhydrolyzable AMP-PNP(+Mg 2+ ) displaced little of the BD-ADP(+Mg 2+ ) in the MSH2 subunit of (CA) 4 -loop-ADP-MSH2-MSH3 within the 1-h observation time. However, the (CA) 4 loopbound ADP-MSH2-MSH3-ATP intermediate dissociated from DNA within minutes (Fig. 6f) . To measure the kinetics of DNA dissociation in the absence of hydrolysis, we incubated FL-labeled (CA) 4 -loop DNA with ADP-MSH2-MSH3-empty, and followed loss of the fluorescein anisotropic signal upon addition of ATP(-Mg 2+ ) (Fig. 6f) . The ADP-MSH2-MSH3-ATP was not stably retained on DNA under these conditions. FL-(CA) 4 -loop dissociation was dependent on the ATP concentration, and FL-(CA) 4 -loop dissociation from ADP-MSH2-MSH3-ATP was nearly complete by 6 min after addition of 500 mM ATP (Fig. 6f) . Thus, under nonhydrolyzing conditions, the MSH2 subunit failed to undergo ADP-ATP exchange, and the ADP-MSH2-MSH3-ATP intermediate dissociated from DNA with ADP still bound.
DISCUSSION
The lesion establishes the MSH2-MSH3 nucleotide-bound form We report here that the nucleotide binding properties of MSH2-MSH3 and MSH2-MSH6 are markedly different. Both MSH2-MSH3 and MSH2-MSH6 maintain a subunit asymmetry for binding nucleotides, but, for yeast or human Msh2-Msh6, subunit occupancy 18 is determined by nucleotide affinity, which is not altered by DNA binding. For human MSH2-MSH3, however, ADP and ATP bind stochastically to either subunit, and DNA binding determines the nucleotide-bound state (Fig. 7, 'strong binding' ). Although two ADPbound forms are present in solution (Fig. 7, strong binding) , only one binds DNA. Thus, DNA binding creates a 'nucleotide signature' in which one ADP binds within the MSH2 subunit and the MSH3 subunit is empty.
Lesion recognition by MSH2-MSH3
Binding to the lesion causes a shift to the doubly occupied state 16, 27, 32 , but the subsequent steps of MSH2-MSH3 recognition differ from those reported for yeast Msh2-Msh6. On the lesion, ADP-MSH2-MSH3-empty binds and hydrolyzes ATP in the MSH3 subunit (Fig. 7, hydrolysis) , which both reduces ADP affinity and increases ATP affinity for the MSH2 subunit. Thus, ADP-ATP exchange converts (CA) 4 -loop-bound ADP-MSH2-MSH3-ATP into an ATP-MSH2-MSH3-ADP intermediate in which ATP hydrolysis is inhibited in the MSH2 subunit (Fig. 7, ADP-ATP exchange) . Msh2-Msh6 also undergoes ADP-ATP exchange in the MSH2 subunit, but has the opposite requirement for ATP hydrolysis: ADP release from DNA-bound Msh2-Msh6 requires ATP stabilization in the MSH6 subunit, while ADP release from DNA-bound MSH2-MSH3 requires ATP hydrolysis in the MSH3 subunit (Fig. 7, hydrolysis) .
Lesion binding inhibits ADP release from the MSH2 subunit relative to homoduplex DNA, whereas ATP hydrolysis in the MSH3 © 2009 Nature America, Inc. All rights reserved. 32 or before moving away from the mismatch (Fig. 7) . The ability for lesion binding to convert MSH2-MSH3 into a distinct nucleotide-bound state poises it to be a molecular sensor for lesion specificity.
METHODS
Protein purification. We overexpressed MSH3 and His 6 -tagged MSH2 in SF9 insect cells using a pFastBac dual expression vector (GIBCO-BRL) that had been subcloned from pFastBac1 plasmids expressing untagged MSH2 and MSH3, a gift from J. Jiricny (Institut for Molecular Cancer Research, Department of Biology, Swiss Federal Institut of Technology). SF9 insect cell pellets expressing the recombinant proteins were obtained under contract with the University of Colorado Cancer Center's Cell Culture Core Facility. We purified and stored proteins as described 30 . A detailed purification protocol is provided in Supplementary Methods online.
DNA substrates and nucleotides. We prepared synthetic DNA substrates as described 30 with an unlabeled 5¢ strand and either an unlabeled 3¢ strand or labeled with fluorescein, as indicated. All complexes were purified by nondenaturing PAGE and stored at 4 1C. Unlabeled ADP, ATP and AMP-PNP were purchased from Sigma and purity was assessed by chromatography (Supple- Fig. 7 online) . [a-32 P]AMP-PNP was purchased from Apparent Affinity Labeling Technologies. All preparations of nucleotides used contained less than 1% contamination of other nucleotides, except AMP-PNP which contained about 20% of a previously recognized but uncharacterized contaminant ( Supplementary Fig. 1a , arrow 4 min, bottom chromatogram). This species underwent further degradation over time to a component that eluted at the same place as AMP when analyzed by MonoQ chromatography (Supplementary Fig. 1a , arrow 3 min, bottom chromatogram). The concentration of AMP-PNP was adjusted for the presence of this contaminant.
Anisotropy. We measured anisotropy using a Safire fluorescent plate reader (Tecan Group) at ambient temperature (21-23 1C) . We added purified proteins at the concentrations indicated and monitored binding to either BD-labeled nucleotides (ADP, ATP or AMP-PNP) or fluorescein-labeled DNA. Proteinnucleotide or protein-DNA complexes were pre-incubated at room temperature for 30 min before measurements. The G-factor was determined by measuring 1:1 complexes of each protein assayed bound to its respective fluorescein-labeled substrate at the highest protein concentration, and polarization calculations were adjusted accordingly using the instrument's software (XFluor). All anisotropy measurements for K d determinations were performed in triplicates and comparable measurements were performed using proteins from different purifications.
Nucleotide binding affinity on DNA-bound complexes. To prepare the DNAbound complexes for these experiments, we used conditions under which most of the DNA-bound complex was primarily ADP-MSH2-MSH3-empty. Specifically, we incubated MSH2-MSH3 with either the (CA) 4 Cross-linking. Cross-linking (Stratalinker) reactions, with respect to time and temperature, were done essentially as described 18 . However, for experiments with both MSH2-MSH6 and MSH2-MSH3, we used buffer conditions that were ideal for MSH2-MSH3 stability and activity: 25 mM HEPES, pH 8.1, 110 mM NaCl, 1.0 mM DTT, 100 mg ml -1 BSA and 10% (v/v) glycerol. Where indicated, Mg 2+ was added to a final concentration of 5 mM and reactions were performed in 10 ml volumes. Experiments were performed at least three times and with different lots of protein and nucleotide preparations, except for © 2009 Nature America, Inc. All rights reserved. In the version of this article initially published, the first sentence referring to Figure 2c (page 552, first paragraph) was incorrect. It should read: "To further test the stochastic binding of nucleotides, we simultaneously added a constant amount (5 µM) of labeled ADP(+Mg 2+ ) and increasing concentrations of unlabeled AMP-PNP(+Mg 2+ ) to MSH2-MSH3 (Fig. 2c, left) ." The error has been corrected in the HTML and PDF versions of the article.
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